https://www.businesswire.com/news/home/20180529005641/en/ > NEWARK, Calif.--(BUSINESS WIRE)--May 29, 2018--Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will participate in the Jefferies 2018 Global Healthcare Conference in New York, NY. > President and Chief Executive Officer, Dan Browne, is scheduled to present on Tuesday, June 5 at 2:00pm ET.